New Hope in [Condition Name] Treatment

A Targeted Trial for an Untreated Core Symptom of Autism

Loudness hyperacusis, described as an unusual intolerance to ordinary environmental sounds, affects between 37 and 46% of autistic individuals. For many, this is not a minor annoyance but a condition with life-altering effects, contributing to anxiety, social withdrawal, and even pain. Despite its pervasiveness, there is no standard, evidence-backed treatment for hyperacusis in the context of autism spectrum disorder (ASD). A new clinical trial is now recruiting to directly test a structured, progressive intervention designed to increase sound tolerance in this specific population.

How the Trial Works: Design and Intervention

The study, titled “Effectiveness of an Individualized Progressive Treatment for Expanding Sound Tolerance in Adults With Autism Spectrum Disorder,” is a randomized controlled crossover trial. It will enroll 40 participants.

The crossover design is a key feature. Participants will be randomly placed into one of two groups. The first group begins the 6-month intervention immediately, followed by a 6-month post-treatment evaluation period. The second group waits for 6 months while being evaluated, then receives the same 6-month intervention. This method allows researchers to compare the effects of the intervention against a period of no treatment within the same participants, which can strengthen the findings.

The intervention itself is described as a “transitional” therapy. It aims to move individuals away from counterproductive habits like constant use of hearing protection and excessive sound avoidance, which can worsen sound sensitivity over time. Instead, it guides them toward structured, progressive sound therapy. The goal is to systematically expand the dynamic range of sound intensity a person can tolerate, aiming to reach a point where everyday sounds are manageable.

Participants will visit the test site monthly for a year for evaluations and intervention activities. They are also required to keep a diary tracking their symptoms and the daily hours spent on the intervention protocols.

The Scientific Rationale Behind the Study

The American Psychiatric Association recognizes hyperacusis as a core feature of ASD, yet research into effective treatments is sparse. The condition’s impact is severe: it can affect social well-being, limit employment opportunities, and increase healthcare-seeking behaviors and risk of self-harm. Autistic self-advocates have identified the development of hyperacusis treatments as a top research priority.

The trial’s approach is based on the theory that maladaptive sound avoidance shrinks a person’s tolerance window. By contrast, carefully controlled and incrementally increased sound exposure—calibrated to each participant’s unique sensitivity thresholds—may help “retrain” the auditory processing and emotional response systems. The researchers will measure success using the Hyperacusis Questionnaire (HQ) scores and Loudness Discomfort Levels (LDLs), which are standard audiological measures for quantifying sound tolerance.

Who Is Eligible to Participate?

The study is looking for a specific group to ensure clear results. Eligible participants must be adults aged 18 to 39 with a formal diagnosis of autism spectrum disorder (including Asperger’s syndrome), which will be confirmed by a score of 65 or greater on the Ritvo Autism Asperger Diagnostic Scale-Revised (RAADS-R).

From an audiological perspective, candidates must have mild-to-severe loudness hyperacusis, indicated by an HQ score of 22 or higher. Their Loudness Discomfort Levels for pure tones must be 80 dB HL or lower at two or more frequencies in at least one ear. They can have no more than slight or mild sensorineural hearing loss and must have normal middle ear function and normal “tone decay” responses. Participants must be able to understand English-informed consent and commit to the monthly visit schedule over the 12-month study period.

Current Status and Future Implications

The trial is currently listed as RECRUITING on ClinicalTrials.gov. Its successful completion could have significant consequences. For patients, it offers the prospect of the first rigorously tested therapeutic protocol for a debilitating symptom that currently has no standard care. For clinicians, it could provide a much-needed tool and framework for supporting autistic adults with sound sensitivity.

For the broader fields of audiology and autism research, positive results would validate a targeted, mechanism-based approach to treating sensory over-responsivity. It would shift the focus from general management to active treatment, potentially improving quality of life across multiple domains for a large subgroup within the autism community.

Source:
Transitional Intervention for Hyperacusis in Autism (ClinicalTrials.gov: NCT07798297)

This article is for informational purposes only. Consult a qualified professional for personalised advice.